590 Anti-CD33 actinium-225 targeted radioimmunotherapy enhances the biologic activity of anti-CD47 antibody immunotherapy in preclinical models of acute myeloid leukemia

• Dale Ludwig,
• Sagarika Pachhal,
• Emily Greer,
• Jesse Hwang,
• Qing Liang,
• Mary Chen,
• Eileen Geoghegan,
• Helen Kotanides,
• Denis Beckford

Affiliations

Dale Ludwig

Aff135 grid.417540.30000000022202544Eli Lilly and Company New York NY USA

Sagarika Pachhal

Actinium Pharmaceuticals, New York, NY, USA

Emily Greer

Actinium Pharmaceuticals, New York, NY, USA

Jesse Hwang

Actinium Pharmaceuticals, New York, NY, USA

Qing Liang

Actinium Pharmaceuticals, New York, NY, USA

Mary Chen

Actinium Pharmaceuticals, New York, NY, USA

Eileen Geoghegan

Actinium Pharmaceuticals, New York, NY, USA

Helen Kotanides

Actinium Pharmaceuticals, New York, NY, USA

Denis Beckford

Actinium Pharmaceuticals, New York, NY, USA